Syngene International Limited
Syngene International Limited is a Bangalore based Custom Research Company that was established as a 99.99% owned subsidiary of Biocon Limited. The company was incorporated on November 18, 1993. The paid-up capital of Syngene International Limited as on March 31st, 2010 is Rs. 28,750,000.
Clinigene International Limited
Clinigene International Limited is a Bangalore based Clinical Research Company that was established as a 100% owned subsidiary of Biocon Limited. The company was incorporated on August 4, 2000. The paid-up capital of Clinigene International Limited as on March 31st, 2010 is Rs. 500,000.
AxiCorp GmbH
AxiCorp GmbH is a Friedrichsdorf (Germany) based pharmaceutical marketing company
and is amongst the fastest growing in Europe. Biocon Limited acquired a majority stake in AxiCorp GmbH (78%) in 2008. As on December 31st 2010, the subscribed capital of AxiCorp is € 248,000.
Biocon Biopharmaceuticals Private Limited (BBPL)
BBPL was set up in 2002 as a Joint Venture company of Biocon Limited in collaboration with CIMAB SA, Cuba. Biocon’s equity participation in this joint venture was 51%. In March 2010, Biocon Limited acquired CIMAB’s 49% stake via its subsidiary Biocon SA. BBPL is now a wholly-owned subsidiary of Biocon Limited. The paid-up capital of BBPL as on March 31st 2010 is Rs. 176,000,000.
Biocon Research Limited (BRL)
Biocon Research Limited was established in 2008 as a 100% owned subsidiary of Biocon Limited. The paid-up capital of BRL as on 31st March 2010 is Rs. 5,00,000.
NeoBiocon FZ LLC
NeoBiocon FZ LLC. is a research and marketing pharmaceutical company based in Abu Dhabi. Incorporated in January 2008, NeoBiocon is a 50:50 joint venture with Dr. B.R.Shetty, Managing Director of NeoPharma, Abu Dhabi. The paid up capital of NeoBiocon as on March 31st, 2010 is AED 300,000.
|
